Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.89 HKD | 0.00% | +4.42% | -47.35% |
30/04 | Transcenta Holding Limited Announces Board and Nomination Changes | CI |
09/04 | Transcenta Partners with Agilent to Develop Claudin18.2 Companion Diagnostic | MT |
Business Summary
Number of employees: 215
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Oncology and Non-oncology Therapeutics
100.0
%
| 118 | 100.0 % | 60 | 100.0 % | -49.78% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 118 | 100.0 % | 60 | 100.0 % | -49.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Xue Ming Qian
FOU | Founder | 57 | 01/10/01 |
Xiao Lu Weng
DFI | Director of Finance/CFO | 47 | 17/21/17 |
Caroline Germa
CTO | Chief Tech/Sci/R&D Officer | 52 | 08/22/08 |
Charlie Qi
CTO | Chief Tech/Sci/R&D Officer | - | 01/20/01 |
Yi Gu
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/19/01 |
Ming Shi
CTO | Chief Tech/Sci/R&D Officer | 59 | - |
Chief Tech/Sci/R&D Officer | 61 | 01/16/01 | |
Feng Ye
COO | Chief Operating Officer | 57 | 01/16/01 |
Wei Wang
IRC | Investor Relations Contact | 41 | 21/22/21 |
Agnes Dai
HRO | Human Resources Officer | - | 01/20/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yi Ning Zhao
FOU | Founder | 53 | 01/18/01 |
Xue Ming Qian
FOU | Founder | 57 | 01/10/01 |
Jia Song Tang
BRD | Director/Board Member | 50 | 14/21/14 |
Zhi Hua Zhang
BRD | Director/Board Member | 43 | 14/21/14 |
Ming Shi
CTO | Chief Tech/Sci/R&D Officer | 59 | - |
Kumar Srinivasan
BRD | Director/Board Member | 59 | 19/22/19 |
Xiao Lu Weng
DFI | Director of Finance/CFO | 47 | 17/21/17 |
Wei Chen
BRD | Director/Board Member | 57 | 23/23/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 436,375,375 | 391,491,827 ( 89.71 %) | 0 | 89.71 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.35% | 98.28M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 6628 Stock
- Company Transcenta Holding Limited